Market Overview

UPDATE: Jefferies Raises PT on Health Management Associates on Continued Positive Outlook


In a report published Wednesday, Jefferies analyst Brian Tanquilut reiterated a Buy rating on Health Management Associates (NYSE: HMA), and raised the price target from $14.50 to $20.00.

In the report, Jefferies noted, “We continue to have a positive view on HMA shares despite the stock's recent run given our belief that the strategic review being undertaken by mgmt will most likely result in the eventual sale of the company. Consistent with yesterday's media reports, we believe hospital providers CYH and HCA are both interested in evaluating an acquisition of HMA. At current levels, we believe HMA's risk-reward is compelling. Raising PT to $20.”

Health Management Associates closed on Tuesday at $16.75.

Latest Ratings for HMA

Dec 2013DowngradesOutperformMarket Perform
Sep 2013DowngradesMarket OutperformMarket Perform
Aug 2013DowngradesBuyNeutral

View More Analyst Ratings for HMA
View the Latest Analyst Ratings

Posted-In: Brian Tanquilut JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (HMA)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Morning Market Movers

Shares of Inovio Pharma Rally Following News of Positive Response Rate from Next-Gen HIV Vaccine